Navigation Links
DTRA/SCC-WMD Announces $1 Million Algorithm Challenge Winner
Date:9/23/2013

Fort Belvoir, VA (PRWEB) September 23, 2013

The winner of DTRA/SCC-WMD’s most recent initiative, “The DTRA Algorithm Challenge” was recently announced by the agency. Team Huson was selected as the winner according to Col Ronald K. Hann, selection authority for the agency’s Chemical and Biological Technologies Directorate. He added that nearly 3,000 individual researchers across the globe submitted algorithm solutions. Team Huson members are: Daniel Huson, Benjamin Buchfink and Xie Chao.

The Algorithm Challenge was an open competition with a $1 million prize for the individual or team that developed an algorithm which can most rapidly and accurately characterize a complex clinical sample based solely on raw DNA sequence data. This particular algorithm challenge focuses on using DNA sequence data in identifying pathogens in complex mixtures from clinical samples. By using sequencing as a diagnostic tool for infectious disease, the DoD will eventually have the ability to diagnose a larger number of threats (known and unknown) than ever before.

“Team Huson’s solution to the challenge will lead to an enhancement of DTRA’s capability to diagnose and treat biothreats to the U.S. Armed Forces by giving DoD the ability to process and analyze biological sequence data rapidly in a realistic, moderate-to-low resource setting,” said Dr. Christian Whitchurch, Devices Branch Manager for DTRA’s Diagnostics, Detection and Disease Surveillance Division. “This is most likely to quickly yield a set of disruptive solutions to the threats posed by known, emerging, or engineered pathogens.”

Background on the competition, including selection criteria is available on the agency’s website at http://www.dtra.mil.

DTRA is a combat support agency of the U.S. Department of Defense, founded in 1998, headquartered at Fort Belvoir, Virginia. Its mission is to safeguard the United States and her Allies from Weapons of Mass Destruction (Chemical, Biological, Radiological, and Nuclear) and High-Yield Explosives by providing capabilities to reduce, eliminate and counter the threat, and mitigate its consequences. Visit us on the Web at http://www.dtra.mil.

Read the full story at http://www.prweb.com/releases/dtra/algorithmchallenge/prweb11150852.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DTRA/SCC-WMD Announces $1 Million Algorithm Challenge
2. Thermax Inc. Announces Price Increase on Ion Exchange Resins
3. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
4. Harwood Feffer LLP Announces Investigation of Verenium Corporation
5. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
6. BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
7. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
8. Natural Skin Care Solution, Probiotic Action Announces the Use of Their Probiotic Cleanser As a Anti-Acne Body Wash
9. Creabilis Announces Treatment of First Patients in its Phase 2b Trial of CT327 in Pruritus in Atopic Dermatitis Patients
10. Neogen announces 1st quarter results conference call
11. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):